Physician profile
William D Weidner
NPI 1881705234
$2,202.45
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $211 · 2021: $581 · 2022: $302 · 2023: $83.43 · 2024: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $441.80 | 2019-2022 | |
| Astellas Pharma US INC | $218.10 | 2019-2024 | Veozah |
| Pacira Pharmaceuticals Incorporated | $137.54 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.30 | 2019-2022 | |
| Astellas Pharma Global Development | $122.05 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $115.43 | 2021 | |
| Mayne Pharma Commercial LLC | $109.56 | 2023-2024 | |
| Exeltis, USA INC. | $85.54 | 2021-2022 | |
| Allergan, INC. | $85.08 | 2019-2020 | |
| Coopersurgical, INC. | $78.89 | 2021 | |
| Organon LLC | $61.20 | 2022-2024 | |
| Therapeuticsmd, INC. | $57.00 | 2019-2022 | |
| Daiichi Sankyo INC. | $56.86 | 2019-2022 | |
| Myovant Sciences INC. | $52.57 | 2022 | |
| Ethicon US, LLC | $52.53 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $45.26 | 2019 | |
| Sumitomo Pharma America, INC. | $41.45 | 2023-2024 | Myfembree |
| Vertical Pharmaceuticals, LLC | $40.75 | 2019-2020 | |
| Pfizer INC. | $37.28 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $33.58 | 2019 | |
| Medtronic, INC. | $29.41 | 2024 | V-Loc 180 |
| Merck Sharp & Dohme LLC | $24.93 | 2019-2021 | |
| Conmed Corporation | $22.73 | 2024 | Airseal |
| Karl Storz Endoscopy-America | $22.21 | 2019 | |
| Asensus Surgical, INC. | $21.46 | 2019 | |
| Baxter Healthcare | $19.68 | 2023 | Floseal |
| Agile Therapeutics, INC. | $17.35 | 2022 | |
| Roche Diagnostics Corporation | $15.83 | 2019 | |
| Gynesonics, INC. | $15.26 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Boston Scientific Corporation | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Weidner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.